Literature DB >> 15931399

Exercise and hypertension.

Tom Baster1, Christine Baster-Brooks.   

Abstract

BACKGROUND: Exercise is advocated for the prevention, treatment and control of hypertension. However, the treatment effect of exercise on hypertension is difficult to determine as many studies are poorly controlled and involve small sample sizes.
OBJECTIVE: This article reviews current knowledge about exercise and blood pressure (BP), and provides a guideline for exercise prescription that considers the health status and age of the patient. DISCUSSION: An evidence based literature analysis by the American College of Sports Medicine indicates that an isolated exercise session (acute effect) lowers BP an average of 5-7 mmHg. Depending upon the degree the patient's BP has been normalised by drug therapy, regular aerobic exercise significantly reduces BP the equivalent of 1 class of antihypertensive medication (chronic effect). For most hypertensive patients exercise is quite safe. Caution is required for those over 50 years of age, and those with established cardiovascular disease (CVD) (or at high CVD risk) and in these patients, the advice of a clinical exercise physiologist is recommended.

Entities:  

Mesh:

Year:  2005        PMID: 15931399

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  5 in total

Review 1.  Evidence for exercise training in the management of hypertension in adults.

Authors:  Alexandra S Ghadieh; Basem Saab
Journal:  Can Fam Physician       Date:  2015-03       Impact factor: 3.275

2.  Exercise-provoked esophageal motility disorder in patients with recurrent chest pain.

Authors:  Jacek Budzyński
Journal:  World J Gastroenterol       Date:  2010-09-21       Impact factor: 5.742

3.  Independent and combined influence of AGTR1 variants and aerobic exercise on oxidative stress in hypertensives.

Authors:  Nicola Fenty-Stewart; Joon-Young Park; Stephen M Roth; James M Hagberg; Samar Basu; Robert E Ferrell; Michael D Brown
Journal:  Blood Press       Date:  2009       Impact factor: 2.835

4.  Pioglitazone improves metabolic markers in patients with type 2 diabetes independently from physical activities: results from the IRIS III study.

Authors:  Thomas Schöndorf; Andreas Pfützner; Georg Lübben; Efstrathios Karagiannis; Werner Roth; Thomas Forst
Journal:  J Diabetes Sci Technol       Date:  2008-03

5.  Explicit and implicit evaluation of physician adherence to hypertension guidelines.

Authors:  Gail Ardery; Barry L Carter; Jessica L Milchak; George R Bergus; Jeffrey D Dawson; Paul A James; Carrie Franciscus; Yoonsang Kim
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-02       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.